KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Asset Utilization Ratio (2016 - 2026)

Pacific Biosciences Of California has reported Asset Utilization Ratio over the past 15 years, most recently at 0.2 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 77.41% year-over-year to 0.2; the TTM value through Dec 2025 reached 0.2, up 77.41%, while the annual FY2025 figure was 0.16, 52.77% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.2 at Pacific Biosciences Of California, up from 0.19 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.2 in Q4 2025 and troughed at 0.07 in Q1 2022.
  • A 5-year average of 0.11 and a median of 0.11 in 2021 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 76.99% in 2021 and later surged 77.41% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.08 in 2021, then decreased by 15.52% to 0.07 in 2022, then soared by 53.78% to 0.11 in 2023, then rose by 3.27% to 0.11 in 2024, then soared by 77.41% to 0.2 in 2025.
  • Business Quant data shows Asset Utilization Ratio for PACB at 0.2 in Q4 2025, 0.19 in Q3 2025, and 0.19 in Q2 2025.